A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies

Clinical trial NCT05567887 · COMPLETED

Trial details

NCT number: NCT05567887
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Multiple Myeloma

Start date: 2022-11-02
Primary completion: 2024-10-02
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.